Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Pazopanib |
Trade Name | Votrient |
Synonyms | GW-786034 |
Drug Descriptions |
Votrient (pazopanib) inhibits VEGFR-1, -2 and -3, KIT, and PDGFR, and FGFR1, 2, and 3, leading to decreased tumor angiogenesis and growth (PMID: 17620431, PMID: 23786770). Votrient (pazopanib) is approved for renal cell carcinoma and soft tissue sarcoma (FDA.gov). |
DrugClasses | FGFR1 Inhibitor 24 FGFR2 Inhibitor 18 FGFR3 Inhibitor 13 KIT Inhibitor 53 PDGFR Inhibitor (Pan) 27 VEGFR Inhibitor (Pan) 33 |
CAS Registry Number | 444731-52-6 |
NCIT ID | C74547 |